Abstract
The South African government is committed to science and technology innovation, to establishing a knowledge-based economy and to harnessing life-sciences research for health and economic development. Given the constraints and the early stage of development of the field as a whole in South Africa, we found an impressive amount of research on human genomic variation in this country. Encouragingly, South Africa is beginning to apply genomics to address local health needs, including HIV and tuberculosis (TB) infections. We document a number of initiatives in South Africa that are beginning to study genetic variation within the various local indigenous populations. Other early initiatives focus on pharmacogenetic studies, mutation characterization in individual disease genes and genome-wide association studies. Public engagement in genomic issues is spear-headed by The Africa Genome Education Institute.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Responsible innovation in synthetic biology in response to COVID-19: the role of data positionality
Ethics and Information Technology Open Access 26 October 2020
-
Ethical and legal implications of whole genome and whole exome sequencing in African populations
BMC Medical Ethics Open Access 28 May 2013
-
Can incubators work in Africa? Acorn Technologies and the entrepreneur-centric model
BMC International Health and Human Rights Open Access 13 December 2010
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jakobsson, M. et al. Genotype, haplotype and copy-number variation in worldwide human populations. Nature 451, 998–1003 (2008).
Li, J. Z. et al. Worldwide human relationships inferred from genome-wide patterns of variation. Science 319, 1100–1104 (2008).
Lohmueller, K. E. et al. Proportionally more deleterious genetic variation in European than in African populations. Nature 451, 994–997 (2008).
Tishkoff, S. A. & Williams, S. M. Genetic analysis of African populations: human evolution and complex disease. Nature Rev. Genet. 3, 611–621 (2002).
Séguin, B., Hardy, B., Singer, P. A. & Daar, A. S. Genomic medicine and developing countries: creating a room of their own. Nature Rev. Genet. 9, 487–493 (2008).
Séguin, B., Hardy, B., Singer, P. A. & Daar, A. S. Human genomic variation initiatives in emerging economies and developing countries. Nature Rev. Genet. 9 (Suppl), S3–S4 (2008).
Public Understanding of Biotechnology. National Biotechnology Strategy for South Africa [online], (2001).
Cloete, T. E., Nel, L. H. & Theron, J. Biotechnology in South Africa. Trends Biotechnol. 24, 557–562 (2006).
Gastrow, M. Great expectations: the state of biotechnology research and development in South Africa. African Journal of Biotechnology 7, 342–348 (2008).
Louet, S. Rainbow biotech — South Africa's emerging sector. Nature Biotechnol. 24, 1313–1316 (2006).
Motari, M. et al. South Africa — blazing a trail for African biotechnology. Nature Biotechnol. 22 (Suppl), DC37–DC41 (2004).
Hodgson, J. South Africa seeks genomic partners. Nature Biotechnol. 19, 601–602 (2001).
Dixon, S., McDonald, S. & Roberts, J. The impact of HIV and AIDS on Africa's economic development. BMJ 324, 232–234 (2002).
Parathyras, J. B. Molecular Genetic Analysis of Human Immunodeficiency Virus Antiretroviral Therapy Response in South Africa — a Pharmacogenetics Study. Thesis, Stellenbosch Univ. [online], (2008).
Babb, C. et al. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis (Edinb.) 87, 295–302 (2007).
Barreiro, L. B. et al. Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoS Med. 3, e20 (2006).
Cooke, G. S. et al. Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis. Am. J. Respir. Crit. Care Med. 178, 203–207 (2008).
Department of Science and Technology. Innovation Towards a Knowledge-Based Economy Ten-Year Plan for South Africa (2008–2018). [online], (2007).
Séguin, B., Hardy, B., Singer, P. A. & Daar, A. S. Genomics, public health and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN). Nature Rev. Genet. 9 (Suppl), S5–S9 (2008).
Acknowledgements
This project was funded by Genome Canada through the Ontario Genomics Institute. The McLaughlin–Rotman Centre for Global Health, Program on Life Sciences, Ethics and Policy is primarily supported by Genome Canada through the Ontario Genomics Institute, the Ontario Research Fund, and the Bill and Melinda Gates Foundation. Other matching partners are listed at the The McLaughlin–Rotman Centre for Global Health web site. A.S.D. and P.A.S. are supported by the McLaughlin Centre for Molecular Medicine.
Author information
Authors and Affiliations
Corresponding author
Related links
Related links
FURTHER INFORMATION
African Genome Education Institute (AGEI)
African Institute of Biomedical Science and Technology (AiBST)
African Society of Human Genetics (AfSHG)
Burden of Disease Research Unit FAQs, Medical Research Council
Centre for Proteomic and Genomic Research (CPGR)
Freedom to Innovate report by the African Union High Level Panel on Modern Biotechnology
McLaughlin–Rotman Centre for Global Health
National Institute of Genomic Medicine (INMEGEN), Mexico
The Division of Human Genetics, University of Cape Town
The Public Understanding of Biotechnology programme
Rights and permissions
About this article
Cite this article
Hardy, BJ., Séguin, B., Ramesar, R. et al. South Africa: from species cradle to genomic applications. Nat Rev Genet 9 (Suppl 1), S19–S23 (2008). https://doi.org/10.1038/nrg2441
Issue Date:
DOI: https://doi.org/10.1038/nrg2441
This article is cited by
-
Responsible innovation in synthetic biology in response to COVID-19: the role of data positionality
Ethics and Information Technology (2021)
-
Ethical and legal implications of whole genome and whole exome sequencing in African populations
BMC Medical Ethics (2013)
-
Can incubators work in Africa? Acorn Technologies and the entrepreneur-centric model
BMC International Health and Human Rights (2010)
-
Erratum: South Africa: from species cradle to genomic applications
Nature Reviews Genetics (2009)
-
News from the antituberculosis front at two recent European meetings
World Journal of Microbiology and Biotechnology (2009)